Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and heal… Read more
Cambridge Nutritional Sciences plc (CNSL) - Total Liabilities
Latest total liabilities as of September 2025: GBX1.64 Million GBX
Based on the latest financial reports, Cambridge Nutritional Sciences plc (CNSL) has total liabilities worth GBX1.64 Million GBX as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cambridge Nutritional Sciences plc - Total Liabilities Trend (2004–2025)
This chart illustrates how Cambridge Nutritional Sciences plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cambridge Nutritional Sciences plc Competitors by Total Liabilities
The table below lists competitors of Cambridge Nutritional Sciences plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GUANGZHOU R&F P-H-
MU:G5HA
|
Germany | €288.48 Billion |
|
Energy Finders Inc
PINK:EGYF
|
USA | $418.86K |
|
Scottish American Investment Co
LSE:SAIN
|
UK | GBX99.70 Million |
|
MetaStat Inc
PINK:MTST
|
USA | $2.28 Million |
|
FieldPoint Petroleum Corporation
PINK:FPPP
|
USA | $6.26 Million |
|
YOMA STRATEGIC HLDG
BE:O3B
|
Germany | €480.99 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Cambridge Nutritional Sciences plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cambridge Nutritional Sciences plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cambridge Nutritional Sciences plc (2004–2025)
The table below shows the annual total liabilities of Cambridge Nutritional Sciences plc from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | GBX2.39 Million | -43.16% |
| 2024-03-31 | GBX4.21 Million | -5.43% |
| 2023-03-31 | GBX4.45 Million | -26.00% |
| 2022-03-31 | GBX6.02 Million | -2.32% |
| 2021-03-31 | GBX6.16 Million | +17.88% |
| 2020-03-31 | GBX5.23 Million | -1.08% |
| 2019-03-31 | GBX5.28 Million | -8.56% |
| 2018-03-31 | GBX5.78 Million | +34.38% |
| 2017-03-31 | GBX4.30 Million | +19.80% |
| 2016-03-31 | GBX3.59 Million | -6.16% |
| 2015-03-31 | GBX3.83 Million | +8.31% |
| 2014-03-31 | GBX3.53 Million | -3.11% |
| 2013-03-31 | GBX3.65 Million | +7.66% |
| 2012-03-31 | GBX3.39 Million | -23.66% |
| 2011-03-31 | GBX4.44 Million | +26.74% |
| 2010-03-31 | GBX3.50 Million | -10.16% |
| 2009-03-31 | GBX3.90 Million | -15.25% |
| 2008-03-31 | GBX4.60 Million | +170.23% |
| 2007-03-31 | GBX1.70 Million | +5570.49% |
| 2005-12-31 | GBX30.00K | +87.50% |
| 2004-12-31 | GBX16.00K | -- |